Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Go back to Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline| (NASDAQ: EWTX) | Delayed: 45.32 -1.62 (3.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.94 | 52 Week High | $ | |||
| Open | $46.79 | 52 Week Low | $ | |||
| Day High | $46.93 | P/E | N/A | |||
| Day Low | $45.32 | EPS | $ | |||
| Volume | 1,991,954 | |||||
